Athira Pharma Stock Price History

ATHA Stock  USD 0.33  0.01  2.94%   
Below is the normalized historical share price chart for Athira Pharma extending back to September 18, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Athira Pharma stands at 0.33, as last reported on the 19th of March, with the highest price reaching 0.34 and the lowest price hitting 0.32 during the day.
IPO Date
18th of September 2020
200 Day MA
1.3241
50 Day MA
0.4671
Beta
3.009
 
Covid
If you're considering investing in Athira Stock, it is important to understand the factors that can impact its price. Athira Pharma secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16 % return per unit of standard deviation over the last 3 months. Athira Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Athira Pharma's risk adjusted performance of (0.15), and Mean Deviation of 3.55 to double-check the risk estimate we provide.
  
The current year's Sale Purchase Of Stock is expected to grow to about 122.1 M, whereas Total Stockholder Equity is forecasted to decline to about 42.6 M. . At present, Athira Pharma's Price Book Value Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.53, whereas Price Earnings Ratio is forecasted to decline to (0.24). Athira Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1605

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsATHA

Estimated Market Risk

 4.69
  actual daily
41
59% of assets are more volatile

Expected Return

 -0.75
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.16
  actual daily
0
Most of other assets perform better
Based on monthly moving average Athira Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Athira Pharma by adding Athira Pharma to a well-diversified portfolio.
Price Book
0.2847
Book Value
1.149
Enterprise Value
-37.3 M
Enterprise Value Ebitda
1.3057
Shares Float
27.6 M

Athira Pharma Stock Price History Chart

There are several ways to analyze Athira Stock price data. The simplest method is using a basic Athira candlestick price chart, which shows Athira Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 7, 20250.6
Lowest PriceMarch 10, 20250.31

Athira Pharma March 19, 2025 Stock Price Synopsis

Various analyses of Athira Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Athira Stock. It can be used to describe the percentage change in the price of Athira Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Athira Stock.
Athira Pharma Price Daily Balance Of Power(0.50)
Athira Pharma Price Action Indicator(0.01)
Athira Pharma Accumulation Distribution 2,410 
Athira Pharma Price Rate Of Daily Change 0.97 

Athira Pharma March 19, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Athira Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Athira Pharma intraday prices and daily technical indicators to check the level of noise trading in Athira Stock and then apply it to test your longer-term investment strategies against Athira.

Athira Stock Price History Data

The price series of Athira Pharma for the period between Thu, Dec 19, 2024 and Wed, Mar 19, 2025 has a statistical range of 0.31 with a coefficient of variation of 17.48. The prices are distributed with arithmetic mean of 0.49. The median price for the last 90 days is 0.53.
OpenHighLowCloseVolume
03/18/2025 0.32  0.34  0.32  0.33  40,973 
03/17/2025 0.33  0.34  0.32  0.33  136,951 
03/14/2025 0.32  0.34  0.32  0.34  118,848 
03/13/2025 0.35  0.35  0.32  0.32  1,663,648 
03/12/2025 0.33  0.34  0.33  0.33  94,426 
03/11/2025 0.31  0.34  0.31  0.33  199,161 
03/10/2025 0.35  0.38  0.30  0.31  225,203 
03/07/2025 0.37  0.37  0.34  0.34  80,704 
03/06/2025 0.37  0.40  0.35  0.35  137,954 
03/05/2025 0.37  0.40  0.37  0.38  71,777 
03/04/2025 0.38  0.38  0.34  0.37  272,409 
03/03/2025 0.41  0.44  0.37  0.38  216,155 
02/28/2025 0.41  0.42  0.39  0.41  116,935 
02/27/2025 0.46  0.46  0.41  0.42  189,571 
02/26/2025 0.39  0.48  0.39  0.44  470,369 
02/25/2025 0.42  0.42  0.37  0.39  303,254 
02/24/2025 0.42  0.43  0.41  0.42  144,047 
02/21/2025 0.44  0.46  0.43  0.43  127,441 
02/20/2025 0.45  0.46  0.44  0.45  83,773 
02/19/2025 0.46  0.46  0.44  0.44  66,780 
02/18/2025 0.47  0.49  0.42  0.46  177,730 
02/14/2025 0.43  0.48  0.43  0.47  126,919 
02/13/2025 0.45  0.45  0.42  0.44  130,354 
02/12/2025 0.45  0.46  0.43  0.45  183,460 
02/11/2025 0.44  0.46  0.43  0.45  206,245 
02/10/2025 0.48  0.52  0.44  0.44  211,725 
02/07/2025 0.50  0.53  0.46  0.48  272,248 
02/06/2025 0.51  0.54  0.48  0.51  257,905 
02/05/2025 0.50  0.55  0.49  0.51  181,221 
02/04/2025 0.49  0.52  0.49  0.52  47,371 
02/03/2025 0.51  0.52  0.48  0.50  388,486 
01/31/2025 0.53  0.57  0.51  0.53  184,829 
01/30/2025 0.54  0.54  0.49  0.53  464,920 
01/29/2025 0.52  0.56  0.51  0.53  274,903 
01/28/2025 0.53  0.53  0.51  0.52  130,704 
01/27/2025 0.53  0.55  0.50  0.52  603,479 
01/24/2025 0.55  0.57  0.53  0.56  89,190 
01/23/2025 0.55  0.56  0.54  0.55  130,492 
01/22/2025 0.52  0.56  0.51  0.55  91,831 
01/21/2025 0.59  0.59  0.51  0.54  315,869 
01/17/2025 0.53  0.55  0.52  0.53  44,571 
01/16/2025 0.55  0.55  0.52  0.53  148,137 
01/15/2025 0.53  0.55  0.52  0.54  176,735 
01/14/2025 0.53  0.57  0.52  0.53  100,815 
01/13/2025 0.56  0.56  0.52  0.53  330,940 
01/10/2025 0.57  0.60  0.56  0.57  215,159 
01/08/2025 0.59  0.61  0.57  0.59  110,595 
01/07/2025 0.58  0.61  0.58  0.60  157,430 
01/06/2025 0.59  0.59  0.56  0.57  191,498 
01/03/2025 0.55  0.58  0.55  0.57  128,319 
01/02/2025 0.59  0.59  0.54  0.55  309,100 
12/31/2024 0.55  0.60  0.55  0.59  335,826 
12/30/2024 0.55  0.57  0.52  0.55  329,849 
12/27/2024 0.52  0.56  0.52  0.55  141,073 
12/26/2024 0.54  0.54  0.51  0.54  587,200 
12/24/2024 0.51  0.56  0.51  0.54  123,222 
12/23/2024 0.55  0.57  0.51  0.51  275,978 
12/20/2024 0.55  0.58  0.52  0.58  223,958 
12/19/2024 0.54  0.56  0.53  0.55  348,198 
12/18/2024 0.59  0.59  0.53  0.54  429,800 
12/17/2024 0.57  0.59  0.56  0.59  292,779 

About Athira Pharma Stock history

Athira Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Athira is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Athira Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Athira Pharma stock prices may prove useful in developing a viable investing in Athira Pharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding38.5 M35 M
Net Loss-86.1 M-81.8 M

Athira Pharma Quarterly Net Working Capital

41.71 Million

Athira Pharma Stock Technical Analysis

Athira Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Athira Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Athira Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Athira Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Athira Pharma's price direction in advance. Along with the technical and fundamental analysis of Athira Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Athira to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Athira Stock analysis

When running Athira Pharma's price analysis, check to measure Athira Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Athira Pharma is operating at the current time. Most of Athira Pharma's value examination focuses on studying past and present price action to predict the probability of Athira Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Athira Pharma's price. Additionally, you may evaluate how the addition of Athira Pharma to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bonds Directory
Find actively traded corporate debentures issued by US companies
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.